Literature DB >> 11560830

FDG uptake in the morphologically normal thymus: comparison of FDG positron emission tomography and CT.

T Nakahara1, H Fujii, M Ide, N Nishiumi, W Takahashi, S Yasuda, A Shohtsu, A Kubo.   

Abstract

The purpose of this study was to evaluate the correlation between fluorine-18 fluorodeoxyglucose (FDG) thymic uptake and a normal appearing thymus on CT. Non-attenuation corrected FDG positron emission tomography (PET) data from 94 young persons (mean age 25.4 years, range 18-29 years) with a normal thymus diagnosed on CT were retrospectively evaluated. No subject had clinical symptoms suggestive of thymus-related disease or mediastinal tumour (follow-up period 6-69 months). PET images were visually assessed and the count ratio between the thymus and the lung (T/L ratio) was calculated. Increased FDG uptake occurred in 32 (34%) subjects. In these 32 cases, the T/L ratio was 2.86+/-0.49 (range 2.02-3.99). In 86 subjects whose CT images were available to calculate the CT attenuation of the thymus (CAT), the CAT value was -17.5+/-45.7 HU (range -103.6 HU to 79.9 HU). The T/L ratio correlated with the CAT value (r=0.58). CAT values in subjects with positive PET findings were significantly higher than CAT values in subjects with negative PET findings (p<0.001, unpaired t-test). These results suggest that even in young adults, if the thymus has a relatively high CT attenuation value, the presence of physiological thymic uptake in FDG-PET is a normal variant. In this study, the diagnosis of normal thymus was based on CT appearance and clinical course. Further studies are needed to clarify the relationship between histopathology and FDG uptake in the thymus.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11560830     DOI: 10.1259/bjr.74.885.740821

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  12 in total

1.  Time-dependent changes in 18F-FDG activity in the thymus and bone marrow following combination chemotherapy in paediatric patients with lymphoma.

Authors:  Ingeborg Goethals; Pieter Hoste; Ciel De Vriendt; Peter Smeets; Joris Verlooy; Hamphrey Ham
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-10-10       Impact factor: 9.236

Review 2.  2-deoxy-2-((18)F)fluoro-D-glucose positron emission tomography/computed tomography imaging in paediatric oncology.

Authors:  John Freebody; Eva A Wegner; Monica A Rossleigh
Journal:  World J Radiol       Date:  2014-10-28

3.  The role of PET-CT in the differential diagnosis of thymic mass after treatment of patients with lymphoma.

Authors:  Bala Basak Oven Ustaalioglu; Mesut Seker; Ahmet Bilici; Nesrin Canpolat; Emre Yıldirim; Umut Kefeli; Recep Ustaalioglu; Burçak Erkol Yilmaz; Taflan Salepci; Nagehan Ozdemir; Mahmut Gumus
Journal:  Med Oncol       Date:  2010-02-13       Impact factor: 3.064

4.  2-Deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography of the head and neck: an atlas of normal uptake and variants.

Authors:  Steven C Burrell; Annick D Van den Abbeele
Journal:  Mol Imaging Biol       Date:  2005 May-Jun       Impact factor: 3.488

5.  Imaging characteristics of pathologically proven thymic hyperplasia: identifying features that can differentiate true from lymphoid hyperplasia.

Authors:  Tetsuro Araki; Lynette M Sholl; Victor H Gerbaudo; Hiroto Hatabu; Mizuki Nishino
Journal:  AJR Am J Roentgenol       Date:  2014-03       Impact factor: 3.959

6.  Intense 18-fluorodeoxyglucose uptake by the thymus on PET scan does not necessarily herald recurrence of thyroid carcinoma.

Authors:  V Godart; B Weynand; E Coche; P De Nayer; C Daumerie
Journal:  J Endocrinol Invest       Date:  2005-12       Impact factor: 4.256

Review 7.  Human T cell reconstitution in DiGeorge syndrome and HIV-1 infection.

Authors:  Lori L Hudson; M Louise Markert; Blythe H Devlin; Barton F Haynes; Gregory D Sempowski
Journal:  Semin Immunol       Date:  2007-11-26       Impact factor: 11.130

Review 8.  Limitations of PET for imaging lymphoma.

Authors:  Sally F Barrington; Michael J O'Doherty
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-05-13       Impact factor: 9.236

Review 9.  [(18)F]2-fluoro-2-deoxy-D-glucose PET/CT in mediastinal masses.

Authors:  S Rankin
Journal:  Cancer Imaging       Date:  2010-10-04       Impact factor: 3.909

10.  Antimicrobial peptides as infection imaging agents: better than radiolabeled antibiotics.

Authors:  Muammad Saeed Akhtar; Muhammad Babar Imran; Muhammad Afzal Nadeem; Abubaker Shahid
Journal:  Int J Pept       Date:  2012-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.